Development of a miRNA-seq based prognostic signature in lung adenocarcinoma

BACKGROUND: We utilized miRNAs expression and clinical data to develop a prognostic signature for patients with lung adenocarcinoma, with respect to their overall survival, to identify high-risk subjects based on their miRNA genomic profile. METHODS: MiRNA expressions based on miRNA sequencing and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Siriwardhana, Chathura, Khadka, Vedbar S., Chen, John J., Deng, Youping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325795/
https://www.ncbi.nlm.nih.gov/pubmed/30621620
http://dx.doi.org/10.1186/s12885-018-5206-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325795/
https://www.ncbi.nlm.nih.gov/pubmed/30621620
http://dx.doi.org/10.1186/s12885-018-5206-8

Ejemplares similares